Company · Toronto, Ontario, Canada
Juno Otc Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 21
- 14 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 18
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| 8-SYMPTOM RELIEF | 02448955 | Marketed | |
| ADVANCED RELIEF EYE DROPS | 02344319 | Marketed | |
| ALLERGY EYE DROPS | 02290596 | Marketed | |
| ALLERGY RELIEF LIQUID GELS | 02528738 | Marketed | |
| ARTIFICIAL TEARS | 02354535 | Marketed | |
| COUGH & COLD RELIEF | 02487004 | Marketed | |
| DIARRHEA RELIEF FAST DISSOLVE | 02499517 | Marketed | |
| DRY EYE TEARS | 02389886 | Marketed | |
| EXTRA STRENGTH BISMUTH | 02475855 | Marketed | |
| IBUPROFEN MINI LIQUID CAPSULES | 02545691 | Marketed | |
| ORIGINAL EYE DROPS | 02273446 | Marketed | |
| DIARRHEA RELIEF LIQUID CAPSULES | 02551586 | Approved | |
| EXTRA STRENGTH ALLERGY RELIEF | 02545071 | Approved | |
| SLEEP AID LIQUID GELS | 02491850 | Approved | |
| ACETAMINOPHEN GELATIN CAPLETS | 02501031 | Cancelled Pre Market | |
| ANTIBACTERIAL WIPES | 02505460 | Cancelled Pre Market | |
| BISMUTH CHEWABLES | 02497174 | Cancelled Pre Market | |
| COOLING MENTHOL NASAL SPRAY | 02460580 | Cancelled Pre Market | |
| DISINFECTING & SANITIZING WIPES | 02508079 | Cancelled Pre Market | |
| LIDO PAIN RELIEF | 02506319 | Cancelled Pre Market | |
| NAPROXEN LIQUID GELS | 02539969 | Cancelled Pre Market |
Notices of Compliance
Newest first.
- IBUPROFEN MINI LIQUID CAPSULESJanuary 21, 2025 · NOC 34710 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN MINI LIQUID CAPSULESJanuary 17, 2025 · NOC 34723 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALLERGY RELIEF LIQUID GELSOctober 15, 2024 · NOC 34207 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DIARRHEA RELIEF LIQUID CAPSULESSeptember 12, 2024 · NOC 34003 · Abbreviated New Drug Submission (ANDS)
- NAPROXEN LIQUID GELSAugust 1, 2024 · NOC 33748 · Supplement to a New Drug Submission (SNDS)
- DIARRHEA RELIEF FAST DISSOLVEAugust 1, 2024 · NOC 33752 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALLERGY RELIEF LIQUID GELSMay 28, 2024 · NOC 33319 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DIARRHEA RELIEF FAST DISSOLVEApril 19, 2024 · NOC 33093 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NAPROXEN LIQUID GELSApril 5, 2024 · NOC 33001 · Supplement to a New Drug Submission (SNDS)
- IBUPROFEN MINI LIQUID CAPSULESMarch 1, 2024 · NOC 32808 · Abbreviated New Drug Submission (ANDS)
- EXTRA STRENGTH ALLERGY RELIEFFebruary 9, 2024 · NOC 32668 · Abbreviated New Drug Submission (ANDS)
- ALLERGY RELIEF LIQUID GELSSeptember 1, 2023 · NOC 31557 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NAPROXEN LIQUID GELSJuly 27, 2023 · NOC 31311 · New Drug Submission (NDS)
- ALLERGY RELIEF LIQUID GELSJuly 7, 2022 · NOC 28553 · Abbreviated New Drug Submission (ANDS)
- DIARRHEA RELIEF FAST DISSOLVEMarch 11, 2022 · NOC 27747 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DIARRHEA RELIEF FAST DISSOLVESeptember 24, 2021 · NOC 26719 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DIARRHEA RELIEF FAST DISSOLVEAugust 23, 2021 · NOC 26500 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DIARRHEA RELIEF FAST DISSOLVEJune 4, 2020 · NOC 23718 · Abbreviated New Drug Submission (ANDS)